A decade-long effort to measure one of physics’ most fundamental constants culminates in a moment of uncertainty and ...
FY26 was a great year for Azul. It saw strong customer demand driven by Finance (43% YoY), Retail (120% YoY), Healthcare (606 ...
Add Yahoo as a preferred source to see more of our stories on Google. Nothing in weather forecasting is simple. But, understanding CAPE goes a long way toward explaining why some clouds produce a ...
Steve Aschburner makes his choice for Kia Rookie of the Year, celebrating a competitive race as the season comes to a close. Steve Aschburner A closer look at Kon Knueppel's rookie season, which ...
SZALINSKI’S SUMMARY: Revenue was up 4.8% in March, or $233 million from the previous year, due to continuing growth in sales and income taxes, according to the Commission on Government Forecasting and ...
The U.S. labor market showed resilience in March 2025, with employment growth rebounding sharply after a sluggish February and the unemployment rate dipping unexpectedly to 4.3%. However, beneath the ...
Robust job growth in March suggests that the labor market remains relatively healthy, allowing officials at the central bank to focus on fighting inflation. By Ben Casselman and Colby Smith The latest ...
BISMARCK, N.D. (Valley News Live) - More than 36,000 hunters took to the field during North Dakota’s 2025 deer gun season, harvesting nearly 21,000 deer, according to the state Game and Fish ...
It isn’t just your eyes. The Rangers profile as a better offensive team through six games this season in comparison to the oftentimes-hard-to-watch performances they put on a year ago. It’s not just ...
Kanye West at Wireless Festival: Mayor Says Ye's Past Actions 'Not Reflective of London's Values' "We are clear that the past comments and actions of this artist are offensive and wrong," a ...
Chewy's revenue rose by 6% last year, and it's expecting even more growth for 2026. Its business model has proven resilient, which could make it an attractive investment. The stock's valuation looks ...
Pfizer started 2026 on a high note despite ongoing skepticism from retail investors. Its key anti-cancer drugs, Padcev, Lorbrena, and Talzenna, showed strong performance in Q4. Accordingly, sales of ...